1 |
Haurani MJ, Foreman K, Yang JJ, Siddiqui A. 5-Fluorouracil treatment of problematic scars. Plast Reconstr Surg 2009;123:139-48; discussion 149-51.
DOI
ScienceOn
|
2 |
Huang JS, Wang YH, Ling TY, Chuang SS, Johnson FE, Huang SS. Synthetic TGF-beta antagonist accelerates wound healing and reduces scarring. FASEB J 2002;16:1269-70.
|
3 |
Muir IF. On the nature of keloid and hypertrophic scars. Br J Plast Surg 1990;43:61-9.
DOI
ScienceOn
|
4 |
Murray RD. Kenalog and the treatment of hypertrophied scars and keloids in Negroes and whites. Plast Reconstr Surg 1963;31:275-80.
DOI
ScienceOn
|
5 |
Ketchum LD, Smith J, Robinson DW, Masters FW. The treatment of hypertrophic scar, keloid and scar contracture by triamcinolone acetonide. Plast Reconstr Surg 1966;38:209-18.
DOI
ScienceOn
|
6 |
Bouchard J, May RM. Stathmokinetic test applied to the study of the physiology of mitosis in normal, cicatricial or cancerous epidermis. Arch Sci Physiolo 1967;21:153-83.
|
7 |
Shridharani SM, Magarakis M, Manson PN, Singh NK, Basdag B, Rosson GD. The emerging role of antineoplastic agents in the treatment of keloids and hypertrophic scars: a review. Ann Plast Surg 2010;64:355-61.
DOI
ScienceOn
|
8 |
Kischer CW, Pindur J, Shetlar MR, Shetlar CL. Implants of hypertrophic scars and keloids into the nude (athymic) mouse: viability and morphology. J Trauma 1989;29:672-7.
DOI
ScienceOn
|
9 |
Grieco MH, Cushman P Jr. Adrenal glucocorticoids after twenty years: a review of their slinically relevant consequences. J Chronic Dis 1970;22:637-41.
DOI
ScienceOn
|
10 |
Robb EC, Waymack JP, Warden GD, Nathan P, Alexander JW. A new model for studying the development of human hypertrophic burn scar formation. J Burn Care Rehabil 1987;8:371-5.
DOI
|
11 |
Goss RJ, Grimes LN. Epidermal downgrowths in regenerating rabbit ear holes. J Morphol 1975;146:533-42.
DOI
|
12 |
Griswold ML Jr. Effects of adrenal cortical preparations on scar hypertrophy. Plast Reconstr Surg (1946) 1954;13:454-61.
DOI
|
13 |
Ladin DA, Garner WL, Smith DJ Jr. Excessive scarring as a consequence of healing. Wound Repair Regen 1995;3:6-14.
DOI
|
14 |
Niessen FB, Spauwen PH, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 1999;104:1435-58.
DOI
ScienceOn
|
15 |
Thomas DW, Hopkinson I, Harding KG, Shepherd JP. The pathogenesis of hypertrophic/keloid scarring. Int J Oral Maxillofac Surg 1994;23:232-6.
DOI
ScienceOn
|
16 |
Sherris DA, Larrabee WF Jr, Murakami CS. Management of scar contractures, hypertrophic scars, and keloids. Otolaryngol Clin North Am 1995;28:1057-68.
|
17 |
Baker BL, Whitaker WL. Interference with wound healing by the local action of adrenocortical steroids. Endocrinology 1950;46:544-51.
DOI
ScienceOn
|
18 |
Mustoe TA, Pierce GF, Morishima C, Deuel TF. Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model. J Clin Invest 1991;87:694-703.
DOI
|
19 |
Manuskiatti W, Fitzpatrick RE. Treatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol 2002;138:1149-55.
DOI
ScienceOn
|
20 |
Morris DE, Wu L, Zhao LL, et al. Acute and chronic animal models for excessive dermal scarring: quantitative studies. Plast Reconstr Surg 1997;100:674-81.
DOI
ScienceOn
|
21 |
Fitzpatrick RE. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 1999;25:224-32.
DOI
ScienceOn
|
22 |
Apikian M, Goodman G. Intralesional 5-fluorouracil in the treatment of keloid scars. Australas J Dermatol 2004;45:140-3.
DOI
ScienceOn
|
23 |
Dockery GL. Hypertrophic and keloid scars. J Am Podiatr Med Assoc 1995;85:57-60.
|
24 |
Goldan O, Weissman O, Regev E, Haik J, Winkler E. Treatment of postdermabrasion facial hypertrophic and keloid scars with intralesional 5-Fluorouracil injections. Aesthetic Plast Surg 2008;32:389-92.
DOI
ScienceOn
|
25 |
Reid RR, Roy N, Mogford JE, Zimmerman H, Lee C, Mustoe TA. Reduction of hypertrophic scar via retroviral delivery of a dominant negative TGF-beta receptor II. J Plast Reconstr Aesthet Surg 2007;60:64-72; discussion 73-4.
DOI
ScienceOn
|